Candriam S.C.A. - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 167 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$176,000
-98.9%
70,000
-94.3%
0.00%
-98.9%
Q2 2020$16,695,000
+1319.6%
1,229,346
+309.8%
0.18%
+1000.0%
Q3 2019$1,176,000
-18.7%
300,0000.0%0.02%
-11.1%
Q2 2019$1,446,000
-41.1%
300,0000.0%0.02%
-41.9%
Q1 2019$2,457,000
+48.1%
300,0000.0%0.03%
+24.0%
Q4 2018$1,659,000
+168.4%
300,000
+328.6%
0.02%
+212.5%
Q3 2018$618,000
-30.6%
70,000
-8.5%
0.01%
-57.9%
Q4 2014$890,00076,4850.02%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$1,471,0001.42%
Orchard Capital Management, LLC 251,826$80,0000.03%
GSA CAPITAL PARTNERS LLP 486,568$154,0000.02%
Icon Wealth Advisors, LLC 400,132$1270.02%
ACADIAN ASSET MANAGEMENT LLC 7,483,053$2,365,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,042,816$646,0000.01%
WIPFLI FINANCIAL ADVISORS LLC, 200,000$63,0000.00%
WEALTH EFFECTS LLC 18,316$6,0000.00%
James J. Burns & Company, LLC 25,142$8,0000.00%
Bayesian Capital Management, LP 68,600$22,0000.00%
View complete list of AKEBIA THERAPEUTICS INC shareholders